{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:11:56Z","timestamp":1789711916006,"version":"4.0.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,21]],"date-time":"2027-01-21T00:00:00Z","timestamp":1800489600000},"content-version":"am","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI163011"],"award-info":[{"award-number":["R01 AI163011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI135972"],"award-info":[{"award-number":["U19AI135972"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Systems"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cels.2025.101452","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:18:48Z","timestamp":1763756328000},"page":"101452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape"],"prefix":"10.1016","volume":"17","author":[{"given":"Zirui","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Escalera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Weshler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Schneidman-Duhovny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cels.2025.101452_bib1","series-title":"Dashboard","author":"Covid","year":"2020"},{"key":"10.1016\/j.cels.2025.101452_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cels.2025.101452_bib3","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.cell.2020.11.032","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cels.2025.101452_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110812","article-title":"LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants","volume":"39","author":"Westendorf","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.cels.2025.101452_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates","volume":"13","author":"Jones","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cels.2025.101452_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","article-title":"Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses","volume":"23","author":"Chen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cels.2025.101452_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.abc7424","article-title":"Broad neutralization of SARS-related viruses by human monoclonal antibodies","volume":"369","author":"Wec","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients\u2019 B Cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cels.2025.101452_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-med-042420-113838","article-title":"SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment","volume":"73","author":"Li","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cels.2025.101452_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.abd2321","article-title":"Structural basis of a shared antibody response to SARS-CoV-2","volume":"369","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib16","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.cell.2021.02.026","article-title":"Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection","volume":"184","author":"Winkler","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cels.2025.101452_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cels.2025.101452_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cels.2025.101452_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib20","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cels.2025.101452_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1126\/science.abo7896","article-title":"Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution","volume":"377","author":"Starr","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adp9279","article-title":"SARS-CoV-2 JN.1 variant evasion of IGHV3-53\/3-66 B cell germlines","volume":"9","author":"Paciello","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cels.2025.101452_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cels.2025.101452_bib25","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.10.2400109","article-title":"Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024","volume":"29","author":"Huiberts","year":"2024","journal-title":"Euro Surveill."},{"key":"10.1016\/j.cels.2025.101452_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41586-024-08315-x","article-title":"Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1","volume":"637","author":"Jian","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.abh2315","article-title":"Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study","volume":"374","author":"Hastie","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cels.2025.101452_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.molmed.2022.08.007","article-title":"Nanobodies as a powerful platform for biomedicine","volume":"28","author":"Shen","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cels.2025.101452_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100865","article-title":"Nanobodies: From High-Throughput Identification to Therapeutic Development","volume":"23","author":"Fridy","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cels.2025.101452_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100745","article-title":"50 Years of structural immunology","volume":"296","author":"Wilson","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cels.2025.101452_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib33","doi-asserted-by":"crossref","first-page":"D1140","DOI":"10.1093\/nar\/gkt1043","article-title":"SAbDab: the structural antibody database","volume":"42","author":"Dunbar","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cels.2025.101452_bib34","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3390\/ijms24065994","article-title":"NANOBODIES\u00ae: A Review of Diagnostic and Therapeutic Applications","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cels.2025.101452_bib35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s42003-023-05332-w","article-title":"SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain","volume":"6","author":"Jiang","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cels.2025.101452_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/302575a0","article-title":"Somatic generation of antibody diversity","volume":"302","author":"Tonegawa","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111004","article-title":"Superimmunity by pan-sarbecovirus nanobodies","volume":"39","author":"Xiang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.cels.2025.101452_bib38","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding","volume":"182","author":"Starr","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cels.2025.101452_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq0839","article-title":"Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models","volume":"377","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib41","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1074\/jbc.M307341200","article-title":"Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm","volume":"279","author":"Stijlemans","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cels.2025.101452_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2023.107996","article-title":"Structure basis of two nanobodies neutralizing SARS-CoV-2 Omicron variant by targeting ultra-conservative epitopes","volume":"215","author":"Sun","year":"2023","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.cels.2025.101452_bib43","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.abe4747","article-title":"Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2","volume":"370","author":"Xiang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-35642-2","article-title":"Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4\/5 and diverse sarbecoviruses","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cels.2025.101452_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89423.3","article-title":"Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus","volume":"12","author":"Ketaren","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.cels.2025.101452_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6230","article-title":"Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape","volume":"371","author":"Koenig","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101918118","article-title":"Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice","volume":"118","author":"Pymm","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2025.101452_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cels.2021.01.003","article-title":"Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies","volume":"12","author":"Xiang","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.cels.2025.101452_bib49","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s42003-023-05241-y","article-title":"VHH CDR-H3 conformation is determined by VH germline usage","volume":"6","author":"Bahrami Dizicheh","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cels.2025.101452_bib50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/procel\/pwae007","article-title":"Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion","volume":"15","author":"Xue","year":"2024","journal-title":"Protein Cell"},{"key":"10.1016\/j.cels.2025.101452_bib54","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMc2410203","article-title":"Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages","volume":"391","author":"Wang","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cels.2025.101452_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20411\/pai.v10i1.752","article-title":"Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies","volume":"10","author":"Planas","year":"2024","journal-title":"Pathog. Immun."},{"key":"10.1016\/j.cels.2025.101452_bib56","article-title":"Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cels.2025.101452_bib57","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1016\/j.cell.2024.09.043","article-title":"Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy","volume":"187","author":"Xiang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cels.2025.101452_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40919-7","article-title":"Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants","volume":"13","author":"Hollingsworth","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cels.2025.101452_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105778","article-title":"Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters","volume":"221","author":"Aksu","year":"2024","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cels.2025.101452_bib60","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S1473-3099(24)00738-2","article-title":"Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutations","volume":"25","author":"Liu","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cels.2025.101452_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23977-1","article-title":"Immunological imprinting of the antibody response in COVID-19 patients","volume":"12","author":"Aydillo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cels.2025.101452_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3324790","article-title":"SARS-CoV-2 Neutralizing Antibodies in Free-Ranging Fallow Deer (Dama dama) and Red Deer (Cervus elaphus) in Suburban and Rural Areas in Spain","volume":"2023","author":"Encinas","year":"2023","journal-title":"Transbound. Emerging Dis."},{"key":"10.1016\/j.cels.2025.101452_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41577-022-00813-1","article-title":"Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection","volume":"23","author":"Zhang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cels.2025.101452_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro1819","article-title":"The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus","volume":"6","author":"Karlsson Hedestam","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cels.2025.101452_bib65","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib66","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrg2053","article-title":"The evolution of epidemic influenza","volume":"8","author":"Nelson","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cels.2025.101452_bib67","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib68","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07467","article-title":"Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity","volume":"4","author":"Altman","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.cels.2025.101452_bib69","article-title":"Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes","volume":"12","author":"Sun","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cels.2025.101452_bib70","article-title":"Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity","volume":"5","author":"Roederer","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cels.2025.101452_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq5720","article-title":"Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concern","volume":"17","author":"Rubio","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cels.2025.101452_bib72","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.abq3773","article-title":"Broadly neutralizing antibodies target the coronavirus fusion peptide","volume":"377","author":"Dacon","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib73","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2220582","article-title":"SARS-CoV-2 spike S2-specific neutralizing antibodies","volume":"12","author":"Li","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.cels.2025.101452_bib74","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73027","article-title":"Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape","volume":"10","author":"Mast","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.cels.2025.101452_bib75","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix-specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.cels.2025.101452_bib93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y","article-title":"Reduced surface: an efficient way to compute molecular surfaces","volume":"38","author":"Sanner","year":"1996","journal-title":"Biopolymers"},{"key":"10.1016\/j.cels.2025.101452_bib99","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","article-title":"Biopython: freely available Python tools for computational molecular biology and bioinformatics","volume":"25","author":"Cock","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2025.101452_bib95","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1093\/bioinformatics\/btab187","article-title":"ProDy 2.0: increased scale and scope after 10 years of protein dynamics modelling with Python","volume":"37","author":"Zhang","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2025.101452_bib96","doi-asserted-by":"crossref","first-page":"189","DOI":"10.12688\/f1000research.7931.1","article-title":"FreeSASA: An open source C library for solvent accessible surface area calculations","volume":"5","author":"Mitternacht","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.cels.2025.101452_bib79","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bioinformatics\/btv552","article-title":"ANARCI: antigen receptor numbering and receptor classification","volume":"32","author":"Dunbar","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2025.101452_bib89","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cels.2025.101452_bib100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib90","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"GROMACS 4.5: a high throughput and highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2025.101452_bib76","article-title":"Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples","volume":"3","author":"Escalera","year":"2022","journal-title":"Star Protoc."},{"key":"10.1016\/j.cels.2025.101452_bib77","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bioinformatics\/btaa739","article-title":"CoV-AbDab: the coronavirus antibody database","volume":"37","author":"Raybould","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2025.101452_bib80","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41592-023-01769-3","article-title":"Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations","volume":"20","author":"Gangavarapu","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cels.2025.101452_bib81","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cels.2025.101452_bib82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41392-022-00910-6","article-title":"Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants","volume":"7","author":"Sun","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cels.2025.101452_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn8897","article-title":"Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529","volume":"376","author":"Zhou","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cels.2025.101452_bib84","article-title":"An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB","volume":"4","author":"He","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cels.2025.101452_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn6859","article-title":"An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses","volume":"14","author":"Liu","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cels.2025.101452_bib86","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205784119","article-title":"A broad and potent neutralization epitope in SARS-related coronaviruses","volume":"119","author":"Yuan","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2025.101452_bib87","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314193120","article-title":"Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2","volume":"120","author":"Rao","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2025.101452_bib88","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nbt.3988","article-title":"MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets","volume":"35","author":"Steinegger","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cels.2025.101452_bib91","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cels.2025.101452_bib92","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.str.2021.11.006","article-title":"Llamanade: An open-source computational pipeline for robust nanobody humanization","volume":"30","author":"Sang","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.cels.2025.101452_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007072","article-title":"Prodepth: predict residue depth by support vector regression approach from protein sequences only","volume":"4","author":"Song","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cels.2025.101452_bib97","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1093\/bioinformatics\/btt560","article-title":"Optimized atomic statistical potentials: assessment of protein interfaces and loops","volume":"29","author":"Dong","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2025.101452_bib98","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/prot.26569","article-title":"Prediction of protein assemblies by structure sampling followed by interface-focused scoring","volume":"91","author":"Olechnovi\u010d","year":"2023","journal-title":"Proteins"}],"container-title":["Cell Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405471225002856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405471225002856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:51:31Z","timestamp":1769028691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405471225002856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2405471225002856"],"URL":"https:\/\/doi.org\/10.1016\/j.cels.2025.101452","relation":{},"ISSN":["2405-4712"],"issn-type":[{"value":"2405-4712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape","name":"articletitle","label":"Article Title"},{"value":"Cell Systems","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cels.2025.101452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101452"}}